Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Before the approval there was no revenue from an approved product. Do you realize what is happening here? I think you fail to see the big picture and how much money you can make here on the rise, and not the fall.
You understand that they have an FDA APPROVED DRUG WHICH IS SELLING WELL AND PRODUCING REVENUE. Also, the fact is that the stock is trending upwards. Another fact is also that the stock is trading well over a hundred percent since the pre-FDA approval.
This is your opportunity to buy more.
Lets see some good volume today. Go Arrayit.
Also remember seeking alpha is just another blog site. People post opinions. Everyone is frustrated with ArrayIt management.
I think management deserves some credit for some of the recent developments.
Let me know when it gets there so I can buy
So no link ok thanks
Like I said, please provide a we link, for people to look for themselves.
Large open market bids
The agenda is to make money whatever means necessary that's it.
Please provide a link
Haha awesome.
No would you like to post any updates here, so we can see.
Belgian white and hefeweizen are my favs right now.
Trying to figure out the new floor. I think it's 4.60
Per market spreads are nothing if there is no volume moving the price before market open so don't worry about it.
There are several catalysts for IPCI and there is a lot of attention now. There's a lot more active participants in this stock now and it hasn't even been a year since FDA approval yet.
There's more to come folks, so just sit back with your cache of shares or add more to your position.
Shorting will be increasingly difficult.
I hope this goes back down to under 10 cents
If true this is very excellent, and will be reflected by ipci stock.
Par is not in the position to buy ipci with the value of the ip and the future prospect. Haha
Looks like you were right cha ching
I love the markets too. It's just a big game. I really big game.
You should hold for a little longer, strong possibility to make a killing given you have enough to load up with.
They will report financial activities related to the first quarter of the fiscal year 2014. There is plenty of free online resources for clarification of this information and what is disclosed in the quarterly reports.
The current earning price target for the first quarter is 11 cents. We will see very soon.
Obviously you have come to save everyone because you are the enlightened one with the altruistic heart looking to save everyone, considering you just created your screen name to tell us this. Same yahoo board message posts. Good luck with your campaign.
Then it goes down.
You're welcome.
This is very good for arrayit and the manufacturing and testing of OvaDx and other diagnostics moving forward.
@arrayit: The newly completed Arrayit cleanrooms tested to a staggering class 1 rating this morning, 100 times better than our previous headquarters!
http://www.cleanairtechnology.com/cleanroom-classifications-class.php
Remember though, this is not a pre-FDA approved stock anymore.
Doogdilinger, I was actually thinking about that, it think yesterday. It was good to see. It also validated to me how the stock will move on a good earnings report or significant news.
Very true.
Very nice
Very true. The remainder of this year is a time of high anticipation for IPCI. The opportunity is just simply tremendous.
I agree definitely. There could be FDA approvals as so as tomorrow. In the presentation the CFO said they expect an FDA approval this year.
They are in a greater position on the bargaining table or partnering.
Speculative hype spike... Lol.
Sounds like that could be a real type of market term for traders.
The long term trend is still in play,
Shorts have an opportunity also right now, but don't get too greedy.
Interesting, I think I'll have to revisit that article again and do some dd. Thanks for bringing it up.